16-30358324-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_015527.4(TBC1D10B):c.2047G>A(p.Val683Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000276 in 1,564,700 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015527.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBC1D10B | NM_015527.4 | c.2047G>A | p.Val683Ile | missense_variant | 9/9 | ENST00000409939.8 | NP_056342.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBC1D10B | ENST00000409939.8 | c.2047G>A | p.Val683Ile | missense_variant | 9/9 | 1 | NM_015527.4 | ENSP00000386538.3 |
Frequencies
GnomAD3 genomes AF: 0.000422 AC: 64AN: 151822Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000264 AC: 46AN: 174438Hom.: 0 AF XY: 0.000279 AC XY: 26AN XY: 93288
GnomAD4 exome AF: 0.000258 AC: 365AN: 1412762Hom.: 2 Cov.: 31 AF XY: 0.000281 AC XY: 196AN XY: 698188
GnomAD4 genome AF: 0.000441 AC: 67AN: 151938Hom.: 1 Cov.: 33 AF XY: 0.000444 AC XY: 33AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 21, 2021 | The c.2047G>A (p.V683I) alteration is located in exon 9 (coding exon 9) of the TBC1D10B gene. This alteration results from a G to A substitution at nucleotide position 2047, causing the valine (V) at amino acid position 683 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at